The Cigna Group (CI) Stock Outlook Revised, Here’s What Analysts Say

Core Insights - The Cigna Group is under close observation by Wall Street analysts, with recent price target adjustments reflecting cautious optimism about its new pharmacy benefit manager model [1][4] - The company reported third-quarter revenue of $69.7 billion, a 10% increase year-over-year, and adjusted earnings of $7.83 per share, up from $7.51 per share in the same quarter last year [2] - Cigna's management emphasized ongoing investments in growth and innovation despite the challenging market environment [2] Price Target Adjustments - Bernstein analyst Lance Wilkes reduced the price target for Cigna to $294 from $346 while maintaining a 'Market Perform' rating [1] - TD Cowen analyst lowered the price target to $333 from $387 but reaffirmed a 'Buy' rating [4] - JPMorgan revised its price target to $375 from $428 while maintaining an 'Overweight' rating [4] Company Overview - The Cigna Group is a Connecticut-based provider of insurance and related products, operating through its subsidiaries, Evernorth Health Services and Cigna Healthcare [5]